CAS: 42371-63-1; 9-[(1S,3S,4R,5S)-4,6,6-Trimethyl-3-Bicyclo[3.1.1]Heptanyl]-9-Borabicyclo[3.3.1]Nonane

该化合物是一种在非对称合成中广泛使用的手性血液试剂,特别是用于对准选择性地将原生氯酮减到二次酒精,其主要优势在于其高立体选择性,其产物往往具有极好的对应性超量(ee)产品.S-enantiomer从Alpine-Borane家族衍生出,它更喜欢以可预测和一致的结果生产(S)酒精.试剂在标准条件下稳定,与一系列功能组相容,因此对复杂的合成应用很有价值.其可靠性和效率在高光学纯度方面使它成为药物和精美化学合成的首选.

结构式图片

欧盟法规

ECHA物质C&L通报

合成工艺路线路线简述

    专利信息


    专利号:US-4727146-A
    优先权日:1980-07-03
    标题 :Synthesis of chiral 1-benzyl-1,2,3,4-tetra-hydroisoquinolines by asymmetric reduction
    发明人:RICE KENNER C
    权利人:US HEALTH
    摘要:In a short total synthesis of morphinan compounds, derivatives of 1-benzyl-1,2,3,4-tetrahydroisoquinoline are produced. Certain of these compounds, although highly aromatic and functionalized, can be optically resolved. The optically active enantiomers can serve as important intermediates for both natural and unnatural opioids. As a special function of this invention, certain of the derivatives, namely 4'-6' and 7'-9', may be hydrogenated to 1'-3' derivative by asymmetric reduction either of the catalytic or chemical type.

    专利号:US-8969596-B2
    优先权日:2008-08-14
    标题:Synthesis of equol
    发明人:STEFFAN BERT
    权利人:STEFFAN BERT
    摘要:Subject of the invention is a method for the production of isoflavanes from isoflavones, whereby in a first reaction step (a) the 4-keto group of the isoflavone is reduced in a enantioselective manner, whilst the 2,3-double bond is maintained, to the 4-hydroxy compound.

    专利号:US-2012094336-A1
    优先权日:2008-08-14
    标题:Synthesis of equol

    专利号:EP-2324004-B1
    优先权日:2008-08-14
    标 题:Synthesis of equol

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2022)
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知